On Dec. 8, the FDA approved the nation’s first medicine based on CRISPR gene-editing technology to be used as a treatment for patients with sickle cell disease, a major scientific advancement that opens the door for future gene therapy approvals for inherited disorders.
Read the full post on Becker's Hospital Review - Healthcare News
